Pathological criteria for multiplex gene-panel testing using next-generation sequencing in non-small cell lung cancer

Shihoko Mizote,Mai Matsumura,Motoki Sekiya,Misaki Sugiyama,Akimasa Sekine,Nobuaki Kobayashi,Toshiaki Kataoka,Hiromichi Iwashita,Koji Okudela

Cancer Treatment and Research Communications（2022）

引用 3|浏览3

暂无评分

摘要

•Oncomine Dx Target Test determines molecular-targeting drugs in lung cancer.•This test requires larger amounts of DNA/RNA than the single-plex tests.•Optimal cutoff values were determined morphometrically for the best success rate.•Pathological criteria were established for accurate Oncomine Dx Target Test.

查看译文

关键词

Biopsy,Lung cancer,Next-generation sequencing,Molecular diagnostic testing,Oncomine DxTT

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要